Autologous Bone Marrow Mononuclear Cell Transplantation in Treating Type 2 Diabetes Mellitus
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bin Wang, M.D.
Division of Hematology and Endocrinology, Peking University Aerospace Centre Hospital
Principal Investigator - Danping Meng, M.D.
Division of Hematology and Endocrinology, Peking University Aerospace Centre Hospital
Principal Investigator - Han Shi, M.D.
Division of Hematology and Endocrinology, Peking University Aerospace Centre Hospital
Principal Investigator - Hong Wang, M.D.
Division of Hematology and Endocrinology, Peking University Aerospace Centre Hospital
Principal Investigator - Lei Lei, M.D.
Division of Hematology and Endocrinology, Peking University Aerospace Centre Hospital
Principal Investigator - Liqin Cui, M.D.
Division of Hematology and Endocrinology, Peking University Aerospace Centre Hospital
Principal Investigator - Liyan Yang, M.D.
Division of Hematology and Endocrinology, Peking University Aerospace Centre Hospital
Principal Investigator - Mingchao Ding, M.D.
Division of Hematology and Endocrinology, Peking University Aerospace Centre Hospital
Principal Investigator - Qiuming Jiang, M.D.
Division of Hematology and Endocrinology, Peking University Aerospace Centre Hospital
Principal Investigator - Song Dong, M.D.
Division of Hematology and Endocrinology, Peking University Aerospace Centre Hospital
Principal Investigator - Xiaolin Jia, M.D.
Division of Hematology and Endocrinology, Peking University Aerospace Centre Hospital
Study Director - Xin Lin, M.D.
Division of Hematology and Endocrinology, Peking University Aerospace Centre Hospital
Principal Investigator - Xiyang Zhang, M.D.
Division of Hematology and Endocrinology, Peking University Aerospace Centre Hospital
Principal Investigator - Yizhong Wang, M.D., Ph.D.
Division of Hematology and Endocrinology, Peking University Aerospace Centre Hospital
Study Chair - Yuanjie Mao, M.D., Ph.D.
Department of Biochemisty, National Cerebral and Cardiovascular Center; Department of Cardiology, China-Japan Friendship Hospital
Study Director - Yufang Li, M.D.
Division of Hematology and Endocrinology, Peking University Aerospace Centre Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Division of Hematology and Endocrinology, Peking University Aerospace Centre Hospital
Beijing, Beijing Municipality, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2011
- Primary completion
- 31 May 2015
- Completion
- 31 Jul 2017
- Last update posted
- 3 Oct 2017
- Registered enrollment
- 1,026
- Registry id
- NCT01677013
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.